NewsBenzinga코야 테라퓨틱스, 근위축성 측삭경화증 치료제 후보 ‘COYA 302’ 평가를 위한 2/3상 ALSTARS 임상시험에 계획된 120명 참가자 모집 완료 발표 코야 테라퓨틱스, 근위축성 측삭경화증 치료제 후보 ‘COYA 302’ 평가를 위한 2/3상 ALSTARS 임상시험에 계획된 120명 참가자 모집 완료 발표 Benzinga 2026.10.05 12:03 (GMT+0) Open on Benzinga Other news Barclays Maintains Equal-Weight on Exelon, Lowers Price Target to $44 The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition. Citizens Financial Analysts Slash Their Forecasts Following Q3 Results Barclays Maintains Overweight on Evergy, Lowers Price Target to $86 Mastercard Brings Its Fraud-Fighting Tools to Stablecoin Payments Barclays Maintains Overweight on Entergy, Lowers Price Target to $115
The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition.
